|
|
|
|
|
|
|
|
|
|
Meet Coriolis Pharma at CPHI Worldwide in Milan to discuss in silico services, formulation development, GMP stability studies, release testing, and product characterization. Click here to learn more
|
|
|
|
FOCUS ON REGULATORY & COMPLIANCE
|
|
|
|
|
|
By Arnaud Deladeriere, Ph.D., Cell & Gene Consulting Inc.
|
European nations offer a welcoming environment for clinical-phase cell and gene therapies. Don't assume the same flexibility carries through to commercialization.
|
|
|
|
|
|
|
|
Enhance Lentiviral Vector Characterization Using Digital PCR
|
|
Poster | By Miroslav Vraneš, Anne Schieren, Philipp Rink, et al., QIAGEN
|
Digital PCR offers a precise, scalable approach to lentiviral vector characterization, enabling reliable genome titer, vector copy number, and RCL detection while reducing variability.
|
|
|
|
|
|
|
|
|
|
|
|
Why Cybersecurity Looks Different In Life Sciences
|
|
Article | Emerson
|
OT cybersecurity can lag in many industries, but life sciences teams take a proactive approach. Their focus on confidentiality and integrity reshapes how risk and protection are prioritized across operations.
|
|
|
|
|
|
|
|
Myths That Make Early CDMO Engagement Look Like A Risk
|
|
Article | By Artur Padzik, 3PBIOVIAN
|
Early CDMO engagement isn’t premature—it prevents CMC-driven delays, reduces comparability risk, and aligns AAV manufacturing decisions with long-term clinical and commercial success.
|
|
|
|
|
|
Modern Lab Maintenance Strategies For Complex Equipment
|
|
Article | PHC Corporation of North America
|
Modern lab equipment is essential to scientific research, but maintaining it is increasingly complex. Discover key challenges and strategies to futureproof your maintenance approach.
|
|
|
|
|
|
Next Generation Sequencing In Viral Safety Testing
|
|
White Paper | By Victor Muthu, Ph.D., Eurofins
|
Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Strategies, Tools, And Techniques Shaping Viral Vector Production | 09.29.26
|
This session examines the latest strategies, tools, and technologies shaping viral vector development and manufacturing for gene therapies. Attendees will learn how advances in vector design, process development, and production are improving safety, potency, scalability, and regulatory readiness. The discussion will also cover common manufacturing challenges and provide guidance for selecting experienced CDMO partners to support efficient, reliable viral vector production. Learn more.
|
|
|
|
REGULATORY & COMPLIANCE SOLUTIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
|